5 ESSENTIAL ELEMENTS FOR AGO TUMOR

The corresponding relative hazard reduction is very depending on the tumor biology than on the nodal status and extent of sickness [62].In case of pT2 pN0 a taxane based polychemotherapy additionally trastuzumab monotherapy is recommended which might be followed in the event of a HR+ tumor by neratinib monotherapy for approximately 1 yr. For indivi